NYSE: NUVB · Biotechnology
Over the past week, Nuvation Bio (NUVB) logged about 32 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 17% bullish but is sharply divided: Reddit runs 50% bullish while News sits at just 0%. Wall Street is more constructive, with 12 of 13 analysts rating NUVB a buy.
There is little buzz around NUVB this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 92% buy share sits next to a crowd that ranges from News at 0% to Reddit at 50%. No other tracker puts the two side by side.
13 analysts have weighed in: a Strong Buy consensus: 12 buy calls against 0 sell, with an average 12-month price target of $13.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 75 points above the crowd average of 17%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 50% bullish while News sits at 0%, a 50-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Nuvation Bio (NUVB) buzz held subdued around 23.5 while the price drifted down 17.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.7M shares. Updated Oct 10, 2026. Over the last 7 trading days, NUVB lost 10.1%. Buzz activity in the recent week averaged 30.8 and was variable, swinging between 23.5 and 44.6. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 8 of the 14 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for NUVB and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live NUVB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 14, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (12 / 1 / 0) |
| Crowd bullish (7d) | 17% |
| Avg price target | $13.00 |
| Most bullish source | Reddit, 50% |
| Most bearish source | News, 0% |
| Sentiment spread | 50 pts |
| Mentions (7d) | 32 |
| Market cap | $1.74B |
| EPS · Beta | -$0.44 · 1.6 |
| Revenue (TTM) | $169.9M · -88% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Nuvation Bio (NUVB) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 17% bullish across 3 active sources. Those sources contribute 32 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Nuvation Bio (NUVB) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Nuvation Bio (NUVB), averaging 17% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 50% bullish and News at 0%, a 50-point spread. On the professional side, 12 of 13 analysts rate NUVB a buy.
Of the 13 analysts covering Nuvation Bio (NUVB), 12 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $13.00. That puts the street ahead of the crowd, which averages 17% bullish.
Nuvation Bio (NUVB)'s cross-source average is bearish at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. Reddit reads 50% bullish, News reads 0% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Nuvation Bio (NUVB) at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is x at 0% bullish. 3-day activity momentum is falling on X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 27 mentions (84% of total volume). News contributes 3 mentions and Reddit contributes 2 mentions. The cross-source average is bearish at 17% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. NUVB's sell signal at 93/100 conviction reflects a bearish cross-source average at 17% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The NUVB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key